Our licensing philosophy
Licensing is at the forefront of Accentus’
commercial strategy. Being an innovative enabling
technology company we see astute licensing as
the optimum means of commercialising our technologies
to the widest possible customer base.
We treat each licensing partner as an individual,
maintaining flexibility to create bespoke arrangements
at all times.
Equally important is our recognition that although
Accentus may consider some of our technologies
as fully developed, when applying them to a new
customer application, there is no guarantee of
success without actually first proving concept
and ultimately commercialising the technology.
We believe that a firm and mutual understanding
of risk and related reward is a necessary prerequisite
to success, as is the agreement of the status
of our technology to a customer’s target.
Our normal and preferred modus operandi in the
initial stages of forging a relationship for a
bespoke application is one of collaborative R&D.
Post agreeing an NDA (Non-Disclosure Agreement)
which has a specific field to fully define the
scope of the discussions, our customers fund a
limited amount of initial rapid screening work
to assess Proof of Concept (i.e. can it be done).
Should we show success, the stepwise, methodical
approach from Proof of Principle (Process Identification:
can it be done on labscale?) through Proof of
Process (can it be repeatably done on lab scale/process
characterisation) through Pilot Trials, ultimately
leading to technology transfer licensing and supply.
This stepwise approach helps focus mutual interests
and most importantly limits risk and can maximise
return on investment.
Top of page
>
|
